Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: The impact on disease outcomes

Clinical and Experimental Rheumatology

Volumn 32, Issue 6, 2014, Pages 904-913

  Cabrera Marroquín, Ricardo ^a   Contreras Yáñez, Irazú ^a   Alcocer Castillejos, Natasha ^a   Pascual Ramos, Virginia ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Disease outcomes; Major depressive disorder; Medication adherence; Medication persistence; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ANTIRHEUMATIC AGENT;

ADULT; AGE DISTRIBUTION; ARTHRITIS; ARTICLE; BECK DEPRESSION INVENTORY; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION ASSESSMENT; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TERTIARY CARE CENTER; VISUAL ANALOG SCALE; ARTHRITIS, RHEUMATOID; ATTITUDE TO HEALTH; DEPRESSIVE DISORDER, MAJOR; MEDICATION COMPLIANCE; MEXICO; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MEXICO; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84925283949     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. KOSINSKI M, KUJAWSKI SC, MARTIN R et al.: Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response. Am J Manag Care 2002; 8: 231-40.
2. SANDERSON T, KIRWAN J: Patient-reported outcomes of arthritis: time to focus on personal life impact measures? Editorial Arthritis Rheum 2009; 61: 1-3.
3. WOLFE F, MITCHELL DM, SIBLEY JT et al.: The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-94.
4. BYKERK VP, SCHOELS MM: Treatment strategies for early rheumatoid arthritis. Curr Opin Rheumatol 2013; 25: 375-83.
5. de KLERK E, van der HEIJDE D, LANDEWÉ R, van der TEMPEL H, URQUHART J, van der LINDEN S: Patient Compliance in Rheumatoid Arthritis, Polymyalgia Rheumatica, and Gout. J Rheumatol 2003; 30: 44-54.
6. GOSSEC L, TUBACH F, DOUGADOS M, RAVAUD P: Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review. Am J Med Sci 2007; 334: 248-54.
7. DEYO RA, INUI TS, SULLIVAN B: Noncompliance with arthritis drugs: magnitude, correlates, and clinical implications. J Rheumatol 1981; 8: 931-6.
8. TUNCAY R, EKSIOGLU E, CAKIR B, GURCAY E, CAKCI A: Factors affecting drug treatment compliance in patients with rheumatoid arthritis. Rheumatol Int 2007; 27: 743-6.
9. GARCÍA-GONZÁLEZ A, RICHARDSON M, GARCÍA POPA-LISSEANU M et al.: Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 2008; 27: 883-9.
10. LORISH CD, RICHARDS B, BROWN S Jr: Perspective of the patient with rheumatoid arthritis on issues related to missed medication. Arthritis Care Res 1990; 3: 78-84.
11. VILLER F, GUILLEMIN F, BRIANÇON S, MOUM T, SUURMEIJER T, van den HEUVEL W: Compliance to drug treatment of patients with rheumatoid arthritis: A 3 year longitudinal study. J Rheumatol 1999; 26: 2114-22.
12. VILLER F, GUILLEMIN F, BRIANÇON S, MOUM T, SUURMEIJER T, van den HEUVEL W: Compliance with drug therapy in rheumatoid arthritis. A longitudinal European study. Joint Bone Spine 2000; 67: 178-82.
13. GRIJALVA CG, CHUNG CP, ARBOGAST PG, STEIN CM, MITCHEL EF JR, GRIFFIN MR: Assessment of adherence to and persistence on disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis. Med Care 2007; 45 (Suppl 2): S66-76.
14. CURKENDALL S, PATEL V, GLEESON M, CAMPBELL RS, ZAGARI M, DUBOIS R: Compliance with biologic therapies for rheumatoid arthritis: do patients out-of-pocket payments matter? Arthritis Rheum 2008; 59: 1519-26.
15. PASCUAL-RAMOS V, CONTRERAS-YÁÑEZ I, VILLA AR, CABIEDES J., RULL-GABAYET M: Medication persistence over two years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and disability. Arthritis Res Ther 2009; 11: R26.
16. CONTRERAS-YÁÑEZ I, PONCE DE LEÓN S, CABIEDES J., RULL-GABAYET M, PASCUALRAMOS V: Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease modifying anti-rheumatic drugs. Am J Med Sci 2010; 340: 282-90.
17. CONTRERAS-YÁÑEZ I, CABIEDES J, VILLA AR, RULL-GABAYET M, PASCUAL-RAMOS V: Persistence on therapy is a major determinant of patient-, physician-, and laboratory reported outcomes in recent onset rheumatoid arthritis patients. Clin Exp Rheumatol 2010; 28: 748-51.
18. HIDER SL, TANVEER W, BROWNFIELD A, MATTEY DL, PACKHAM JC: Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic. Rheumatology (Oxford) 2009; 48: 1152-4.
19. MARGARETTEN M, JULIAN L, KATZ P, YELIN E: Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumatol 2011; 6: 613-23.
20. ABDEL-NASSER AM, ABD El-AZIM S, TAAL E, El-BADAWY SA, RASKER JJ, VAKENBURG HA: Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurrence and determinants. Br J Rheumatol 1998; 37: 391-7.
21. WRIGHT GE, PARKER JC, SMARR KL, JOHNSON JC, HEWETT JE, WALKER SE: Age, depressive symptoms, and rheumatoid arthritis. Arthritis Rheum 1998; 41: 298-305.
22. PINCUS T, GRIFFITH J, PEARCE S, ISENBERG D: Prevalence of self-reported depression in patients with rheumatoid arthritis. Br J Rheumatol 1996; 35: 879-83.
23. DICKENS C, McGOWAN L, CLARK-CARTER D, CREED F: Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002; 64: 52-60.
24. TEKAYA R, SAADI F, MAHMOUD I, SAIDANE O et al.: Assessment of depression in rheumatoid arthritis: a cross sectional study. Presse Med 2012; 41: e220-5.
25. SUÁREZ-MENDOZA AA, CARDIEL MH, CABALLERO-URIBE CV, ORTEGA-SOTO HA, MÁRQUEZ-MARÍN M: Measurement of depression in Mexican patients with rheumatoid arthritis: validity of the Beck Depression Inventory. Arthritis Care Res 1997; 10: 194-9.
26. McNAMARA D: Depression interferes with anti-TNF therapy. Rheumatol News 2007; 6: 1.
27. WONG M. MULHERIN D: The influence of medication beliefs and other psychosocial factors on early discontinuation of disease modifying anti-rheumatic drugs. Musculoskelet Care 2007; 5: 148-59.
28. SCHERRER JF, VIRGO KS, ZERINGUE A et al.: Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis. Gen Hosp Psychiatry 2009; 31: 353-9.
29. TREHARNE GJ, LYONS AC, KITAS GD: Suicidal ideation in patients with rheumatoid arthritis: research may help identify patients at high risk. BMJ 2000; 321: 1290.
30. ANG DC, CHOI H, KROENKE K, WOLFE F: Comorbid depression is an independent risk factor for mortality in rheumatoid arthritis. J Rheumatol 2005; 32: 1013-9.
31. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
32. ZINK A, LISTING J, KARY S et al.: Treatment continuation in patients receiving biological agents or conventional DMARD therapy. Ann Rheum Dis 2005; 64: 1274-9.
33. STUCKI G, LIANG MH, STUCKI S, BRÜHLMANNP, MICHEL BA: A self-administered rheumatoid Arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995; 38: 795-8.
34. KOSINSKI M, KELLER SD, WARE JE Jr, HATOUM HT, KONG SX: The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: Relative validity of scales in relation to clinical measures of arthritis severity. Med Care 1999; 37: MS23-39.
35. RAMEY DR, RAYNAULD JP, FRIES JF: The health assessment questionnaire 1992; status and review. Arthritis Care Res 1992; 5: 119-29.
36. van den BEMT BJF, ZWIKKER HE, van den ENDE CH: Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol 2012; 8: 337-51.
37. SHEEHAN DB, LECRUBIER Y, SHEEHAN KH et al.: The Mini-International Neuropsychiatric interview (M.I.N.I.): the development and validation of a structures diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl. 20): 22-33.
38. ORTIGO KM, BRADLEY B, WESTEN D: An empirically based prototype diagnostic system for DSM-IV and ICD-11. In: MILLION T, KRUEGER R, SIMONSEN E (Eds.): Contemporary Directions in Psychopathology: Scientific Foundations of the DSM-IV and ICD-11. New York, Guilford 2012: 374-90.
39. HAWLEY DJ, WOLFE F: Depression is not more common in rheumatoid arthritis: A 10-year longitudinal study of 6153 patients with rheumatic disease. J Rheumatol 1993; 20: 2025-31.
40. BLALOCK SJ, de VELLIS RF: Rheumatoid arthritis and depression: An overview. Bull Rheum Dis 1992; 41: 6-8.
41. CALLAHAN LF, KAPLAN MR, PINCUS T: The Beck Depression Inventory, Center for Epidemiological Studies Depression Scales (CES-D), and General Well-Being Schedule Depression Subscale in Rheumatoid Arthritis: Criterion contamination of responses. Arthritis Care Res 1991; 4: 3-11.
42. Cross-NATIONAL Collaborative Group: The changing rate of major depression: crossnational comparisons. JAMA 1992; 268: 3098-105.
43. MODY GM, CARDIEL MH: Challenges in the management of rheumatoid arthritis in developing countries. Best Pract Res Clin Rheumatol 2008; 22: 621-41.
44. KARPOUZAS A, DOLATABADI S, MORAN S, LI N, NICASSIO PM, WEISMAN MH: Correlates and predictors of disability in vulnerable US Hispanics with Rheumatoid Arthritis. Arthritis Rheum 2012; 64: 1274-81.
45. ATTKISSON CC, ZICH JM: Depression in primary care: Screening and detection. London: Routledge, 1990: 1-11.
46. MURPHY S, CREED F, JAYSON MIV: Psychiatric disorder and illness behavior in rheumatoid arthritis. Br J Rheumatol 1988; 27: 357-63.
47. RAHTBUN A, REED GW, HAROLD LR: The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: A systematic review. Rheumatology 2013; 52: 1785-94.
48. DIMATTEO MR, LEPPER HS, CROGHAN TW: Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effect of anxiety and depression on patient adherence. Arch Inter Med 2000; 160: 2101-7.
49. NEWMAN SP, FITZPATRICK R, LAMB R, SHIPLEY M: The origins of depressed mood in rheumatoid arthritis. J Rheumatol 1989; 16: 740-4.
50. MOUM T: Is subjective well-being a predictor of non-response in broad population surveys? Soc In Res 1994; 32: 1-20.